Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:4.1.1.32 (phosphoenolpyruvate carboxykinase)
4,204 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Enzymes representative of, and related to, the pentose phosphate pathway, glycolysis, and the tricarboxylic acid cycle have been demonstrated in supernatant and lamellar fractions of Anabaena cylindrica cultured in the presence of atmospheric nitrogen, ammonia, nitrite, and nitrate. Nitrogen-fixing and ammonia-assimilating algae contained essentially similar levels of most enzymes tested, with the notable exception of glyceraldehyde-3-phosphate dehydrogenase which showed increased NADPH-linked activity with concomitant diminution of NADH-linked activity when ammonia was supplied. The provision of nitrite or nitrate caused significant enhancements of glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and the related hexokinase and phosphohexoisomerase. Reduced activities of pyruvate kinase, malate dehydrogenase, phosphoenolpyruvate carboxylase, and both NADH and NADPH oxidoreductases were recorded for nitrate-grown alga.The stimulation of the pentose phosphate pathway, at the partial expense of glycolysis and the tricarboxylic acid cycle, in algae cultured with nitrite and nitrate was interpreted to be due to additional NADPH requirements imposed by induced nitrite reductase. Modification of the pyridine nucleotide linkage of glyceraldehyde-3-phosphate dehydrogenase and the oxidoreductases was attributed to diversion of reductant to nitrite and nitrate reductases and nitrogenase. The results are considered to indicate regulation of blue-green algal metabolism determined by the availability of pyridine nucleotides.
...
PMID:The influence of inorganic nitrogen supply on carbohydrate and related metabolism in the blue-green alga, Anabaena cylindrica Lemm. 2445 90

The need for new antimalarials is persistent due to the emergence of drug resistant parasites. Here we aim to identify new drug targets in Plasmodium falciparum by phylogenomics among the Plasmodium spp. and comparative genomics to Homo sapiens. The proposed target discovery pipeline is largely independent of experimental data and based on the assumption that P. falciparum proteins are likely to be essential if (i) there are no similar proteins in the same proteome and (ii) they are highly conserved across the malaria parasites of mammals. This hypothesis was tested using sequenced Saccharomycetaceae species as a touchstone. Consecutive filters narrowed down the potential target space of P. falciparum to proteins that are likely to be essential, matchless in the human proteome, expressed in the blood stages of the parasite, and amenable to small molecule inhibition. The final set of 40 candidate drug targets was significantly enriched in essential proteins and comprised proven targets (e.g. dihydropteroate synthetase or enzymes of the non-mevalonate pathway), targets currently under investigation (e.g. calcium-dependent protein kinases), and new candidates of potential interest such as phosphomannose isomerase, phosphoenolpyruvate carboxylase, signaling components, and transporters. The targets were prioritized based on druggability indices and on the availability of in vitro assays. Potential inhibitors were inferred from similarity to known targets of other disease systems. The identified candidates from P. falciparum provide insight into biochemical peculiarities and vulnerable points of the malaria parasite and might serve as starting points for rational drug discovery.
...
PMID:In silico prediction of antimalarial drug target candidates. 2453 80